Search clinical trials for: Placebo (NNC6019-0001)

Total 54788 results

BioMarin Pharmaceutical

Completed

Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU

Phenylketonuria

United States
PharmAbcine

Completed

Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma

Recurrent Glioblastoma
Novo Nordisk A/S

Withdrawn

A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Inflammation | Rheumatoid Arthritis
Oramed, Ltd.
Integrium

Completed

A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
BiondVax Pharmaceuticals ltd.

Completed

A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers

Influenza

Israel
Hospital Vall d'Hebron

Unknown

Clinical Trial to Evaluate the Effectiveness of Acupuncture as a Treatment in Patients Diagnosed With CFS. (AV/AS)

Pain. | Cognitive Impairment | Sleep Disturbances | Chronic Fatigue Syndrome. | Muscular Diseases.

Spain
Pfizer

Terminated

Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients

Alzheimer Disease

United States, Spain, Belgium, France, Australia, Japan, Netherlands, Portugal, Croatia, United Kingdom, Germany, Austria, Sweden, Slovakia, Serbia, Argentina, Italy, Chile, Finland, New Zealand, South Africa, Switzerland, Mexico, Poland
Neurona Therapeutics
California Institute for Regenerative Medicine (CIRM)

Recruiting

FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis

United States
Olympus Biotech Corporation

Completed

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study (TRANS-North)

Diabetic Foot Ulcer of Neuropathic Origin

Belgium, Germany, Poland, Croatia, Bulgaria, Denmark, Slovakia, Hungary, Netherlands, Sweden
Olympus Biotech Corporation

Completed

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study (TRANS-South)

Diabetic Foot Ulcer of Neuropathic Origin

France, Italy, Hungary, Czech Republic
SCAI Therapeutics

Completed

Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis

Dry Eye Syndromes

Korea, Republic of
ScarX Corp

Completed

Dose Ranging Study to Evaluate the Safety and Tolerability of SCX-001 Cream in Healthy Volunteers With Induced Dermal Incisions

Scarring

Canada
Pfizer

Terminated

Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients

Alzheimer Disease

Canada, Finland, United States, Spain, Belgium, France, Japan, Netherlands, Portugal, Australia, Croatia, United Kingdom, Italy, Argentina, Germany, Slovakia, Serbia, Russian Federation, Chile, New Zealand, South Africa, Switzerland, Mexi... and more
Aerovance, Inc.

Completed

A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema

Atopic Eczema

United Kingdom
AtoGen Co. Ltd
ATOGEN AUSTRALIA PTY LTD

Recruiting

Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women

Bacterial Infections | Vaginal Disease | Vaginitis | Infection, Bacterial | Bacterial Vaginosis

Australia
University of California, San Diego
Center for Medicinal Cannabis Research

Recruiting

Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity

HIV | Cannabis Use

United States
Oramed, Ltd.
Integrium

Completed

A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics

Diabetes Mellitus Type 1

United States
Baylx Inc.

Not yet recruiting

Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis

Rheumatoid Arthritis
Eisai Limited

Completed

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Panoptes Pharma GmbH

Completed

A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers

Keratoconjunctivitis | Ocular Surface Disease

Austria
Applied Therapeutics, Inc.

Active, not recruiting

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

Diabetic Cardiomyopathies

United States, France, Spain, Australia, Canada, United Kingdom, Germany, Czechia, Hong Kong, Poland
University of Kentucky
Alltech Life Sciences Inc.

Completed

AT-001 for Long-term Preservation of Brain Health in Aging (ALPHA)

Oxidative Stress

United States
Sarepta Therapeutics, Inc.
Hoffmann-La Roche

Enrolling by invitation

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) (ENDEAVOR)

Muscular Dystrophy, Duchenne

United States
Centro de Estudios en Infectogía Pediatrica

Withdrawn

Safety and Immunogenicity of Inactivated Heterologous Booster Vaccination

COVID-19

Colombia
Shiga University
Tokyo University

Completed

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid Tumors

Solid Tumors

Japan
Centers for Disease Control and Prevention
Department of Health and Human Services; University of Sierra Leone; Ministry... and other collaborators

Completed

STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola) (STRIVE)

Hemorrhagic Fever, Ebola

Sierra Leone
Prescient Therapeutics, Ltd.
VioQuest Pharmaceuticals

Completed

Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies

Leukemia | Hematologic Malignancies

United States
Inotek Pharmaceuticals Corporation

Completed

A Study of INO-1001, an Intravenous PARP (Poly [ADP Ribose] Polymerase) Inhibitor in Acute Heart Attack Patients Undergoing Primary Percutaneous Coronary Intervention

Acute Myocardial Infarction

United States, Israel
Hvivo
Prep Biopharm Limited

Completed

Study Examining PrEP-001 in Healthy Subjects

Influenza A H3N2

United Kingdom
Light Chain Bioscience - Novimmune SA

Completed

NI-0401 in Active Crohn's Disease

Moderate to Severe Crohn's Disease
University of Kansas Medical Center

Recruiting

Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease

Acute Graft Versus Host Disease

United States
HK inno.N Corporation

Not yet recruiting

A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy Volunteers

Healthy

Korea, Republic of
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Recruiting

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

Hemophilia

China
Hoffmann-La Roche
Sarepta Therapeutics, Inc.

Recruiting

A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD) (ENVOL)

Duchenne Muscular Dystrophy

Spain, Germany, Italy
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Novikang Medical Technology Co., LTD

Completed

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

Hemophilia

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Unknown

A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

Hemophilia

China
Welichem Biotech Inc.

Completed

A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks (134993)

Psoriasis
Welichem Biotech Inc.

Completed

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Dermatitis, Atopic

Canada
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Cytomegalovirus Vaccine in Healthy Participants

Precancerous/Nonmalignant Condition

United States
Novo Nordisk A/S

Recruiting

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

Growth Hormone Disorder | Growth Hormone Deficiency in Children

United States, Japan, Israel, India, Austria, Slovenia, Belgium, Brazil, France, Germany, Sweden, Turkey, Ukraine
Novo Nordisk A/S

Completed

Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects

Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

United Kingdom
National Institute of Diabetes and Digestive and...
Novo Nordisk A/S

Completed

A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 (TOPPLE T1D)

Type I Diabetes

United States
Novo Nordisk A/S

Terminated

A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers

Obesity | Metabolism and Nutrition Disorder

United States
Eli Lilly and Company
Versanis Bio, Inc.

Active, not recruiting

Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

Obesity | Obese | Overweight or Obesity

United States, Australia, New Zealand
Oramed, Ltd.
Integrium

Completed

Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus

Diabetes Type 2

United States
Oramed, Ltd.
Integrium

Terminated

Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Oramed, Ltd.
Integrium

Completed

A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes

Type 1 Diabetes

United States
Oramed, Ltd.
Integrium

Completed

Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)

Diabetes Mellitus Type 2

United States
Ablynx

Completed

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic

United States, Hungary, Spain, Philippines, Poland, Serbia, Argentina, Chile, Czechia, Germany, Korea, Republic of, Mexico, Peru, Portugal, Russian Federation, Taiwan, Ukraine
Turning Point Therapeutics, Inc.

Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Lymphoma | Locally Advanced Solid Tumors | Metastatic Solid Tumors | Primary CNS Tumors

United States, Korea, Republic of, Spain, Singapore, Taiwan, Australia, Italy, Canada, France, Denmark, United Kingdom

Search clinical trials for: Placebo (NNC6019-0001)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations